Bariatric surgery is the most effective long-term treatment for morbid obesity, reducing obesity-associated comorbidities. The purpose of the present study was to evaluate the UCP3 promotor (-55C-->T) polymorphism outcomes 1 year after biliopancreatic diversion in morbidly obese patients.
Institute of Endocrinology and Nutrition, Medicine School, Unit of Investigation, RD 056/0013, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain. dadluis@yahoo.es